logo

NEOG

Neogen·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About NEOG

Neogen Corporation

A company that develops diagnostic test kits for food safety, and pharmaceuticals and vaccines for animal safety

Healthcare Equipment and Supplies
--
11/10/1989
NASDAQ Stock Exchange
2,974
05-31
Common stock
620 Lesher Place Lansing Michigan 48912
--
Founded in June 1981, Neogen Corporation is a Michigan corporation whose actual operations began in 1982. Neogen and its subsidiaries develop, manufacture and sell a range of products and services dedicated to food and animal safety. The Company's food safety segment primarily consists of diagnostic test kits and complementary products (such as culture media) sold to food manufacturers and processors to detect dangerous and unexpected substances in human food and animal feed, such as food-borne pathogens, spoilage organisms, natural toxins, food allergens, genetic modification, ruminant by-products, meat speciation, drug residues, pesticide residues and general health issues.

Earnings Call

Company Financials

EPS

NEOG has released its 2026 Q1 earnings. EPS was reported at 0.04, versus the expected 0.04, meeting expectations. The chart below visualizes how NEOG has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NEOG has released its 2026 Q1 earnings report, with revenue of 209.19M, reflecting a YoY change of -3.58%, and net profit of 36.34M, showing a YoY change of 388.19%. The Sankey diagram below clearly presents NEOG's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime